首页> 外国专利> PHARMACEUTICAL COMPOSITIONS CONTAINING ANTIHYPERTENSIVE SUBSTANCES COMBINED WITH PLATELET AGGREGATION INHIBITING SUBSTANCES FOR USE IN THE TREATMENT AND PREVENTION OF ISCHEMIC VASCULAR EVENTS.

PHARMACEUTICAL COMPOSITIONS CONTAINING ANTIHYPERTENSIVE SUBSTANCES COMBINED WITH PLATELET AGGREGATION INHIBITING SUBSTANCES FOR USE IN THE TREATMENT AND PREVENTION OF ISCHEMIC VASCULAR EVENTS.

机译:包含抗高血压药物与血小板聚集抑制物质组合的药物组合物,用于治疗和预防缺血性血管事件。

摘要

The invention relates to the pharmaceutical industry in general and in particular to the pharmaceutical industry involved in the production of medicaments for controlling systemic arterial hypertension and preventing ischemic vascular events. More specifically, the invention relates to a composition containing a hypotensive antagonist substance of angiotensin II receptors which is combined with a platelet aggregation inhibiting agent. The composition is characterised in that the aforementioned combination or association consists of a selected angiotensin II receptor antagonist substance known as Losartan and a platelet aggregation inhibiting agent known as acetylsalicylic acid, in order to produce a product which has a synergistic effect for the treatment of systemic arterial hypertension and which prevents the risk of ischemic vascular events, with fewer side effects.
机译:本发明总体上涉及制药工业,尤其涉及涉及用于控制系统性动脉高血压和预防缺血性血管事件的药物生产的制药工业。更具体地,本发明涉及包含与血管紧张素II受体的降压拮抗剂物质结合的血小板凝集抑制剂的组合物。该组合物的特征在于,上述组合或结合由选定的称为洛沙坦的血管紧张素II受体拮抗剂物质和称为乙酰水杨酸的血小板凝集抑制剂组成,以产生对全身性治疗具有协同作用的产物。动脉高血压,可预防缺血性血管事件的风险,且副作用较少。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号